RECENT NEWS

Stago UK is introducing a unique autotransfusion system, able to preserve functional platelets as well as red blood cells. It offers a safer alternative to scarce, risky and expensive blood transfusion products. Stago UK has partnered with i-SEP, one of France’s most innovative MedTech companies, to distribute its novel ‘same’ system.

Paige, a global leader in clinical AI applications for cancer, in collaboration with Microsoft, has unveiled the second generation of Virchow, its million-slide foundation model for cancer.

Beckman Coulter Life Sciences, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an automated solution enabling comprehensive genomic profiling of tumour samples.

MIP Discovery has announced the company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector.

Fimlab Laboratories has selected Aiforia Technologies as the provider for breast and prostate cancer diagnostics solutions. Fimlab is Finland’s largest healthcare laboratory company, owned by the wellbeing services counties of Pirkanmaa, Central Finland, Kanta-Häme, Ostrobothnia, and Päijät-Häme.

Research published in the Journal of Parkinson's Disease shows promise for finding an objective, quantifiable, less-invasive biomarker for diagnosing Parkinson's disease.

National charity Group B Strep Support has produced a new free eLearning module on group B Streptococcus (GBS), to be used as a vital resource for midwives, doctors and health professionals in maternity services. It offers vital evidence-based education on GBS to enhance the care of pregnant women and people, and their babies, and ultimately will help save lives.

Do-it-yourself human papillomavirus (HPV) tests could allow an extra one million women in England to participate in cervical screening over the next three years.

Bio-Rad Laboratories has expanded its Pioneer Antibody Discovery Platform services with the addition of fast generation and screening of bispecific antibodies, based on the company’s proprietary SpyLock technology.

Thermo Fisher Scientific recently announced that it has been 510k cleared, following US Food and Drug Administration (FDA) requirements, to market its Optilite Freelite assays’ claim for the evaluation of monoclonal gammopathy of undetermined significance (MGUS).

Agilent Technologies has received US Food and Drug Administration (FDA) approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovial sarcoma who may be eligible for treatment with TECELRA (afamitresgene autoleucel, also known as afami-cel or ADP-A2M4), a MAGE-A4-directed engineered TCR T-cell therapy.

INTEGRA’s innovative MAG and HEATMAG modules are designed to overcome problems with repetitive magnetic bead clean-up by automating the movement of a magnet to capture magnetic beads, simplifying proteomics and molecular biology laboratory preparation protocols.

Torrey Pines Scientific has launched its EchoTherm Model IC50 Peltier driven Chilling/Heating Dry Bath with exact sample temperature control.

An independent review of the Care Quality Commission (CQC) has identified significant internal failings which is hampering its ability to identify poor performance at hospitals, care homes and GP practices.

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.

A new report from IBMS and Abbott, ‘Community Diagnostics: Scaling Point-of-Care Testing for Patient-Centred Outcomes’ provides a POCT roadmap for the new government, healthcare organisations and primary care providers.

London pathology services provider Synnovis is continuing to recover services following the cyber attack on 3 June.

Sophia Genetics has announced that OncoHelix, an internationally recognised research and diagnostics laboratory for precision diagnostics, will implement MSK-ACCESS powered with SOPHiA DDM. The organisation, which currently uses the SOPHiA DDM platform for myeloid testing, will use the new liquid biopsy solution to advance its oncology testing capabilities.

BD (Becton Dickinson) and Quest Diagnostics have announced a global collaboration agreement to develop, manufacture and commercialise flow cytometry-based companion diagnostics (CDx) intended to help select the best treatment for patients with cancer and other diseases.

Proscia has introduced the next version of its enterprise pathology platform Concentriq AP. The release includes new functionality that advances the impact of AI in shaping pathologists’ understanding of four of the top five most common cancers worldwide.